Corporate News     06-Jun-22
Gufic Biosciences launches indigenously produced Dual Chamber Bags
Gufic Biosciences has targeted to capture major share of Rs. 3000 crore lyophilized antibacterial market in India. Gufic has launched New Drug Delivery System: Dual Chamber Bags at affordable price for the first time in India.

Contributing immensely to the government's ambitious Make in India drive, Gufic has collaborated with its European counterpart to manufacture this new technology indigenously in India. Until now the dual chamber bags have been largely imported in India at a very high cost to the patients. On the contrary, Gufic has not only launched high-quality Dual Chamber Bags at an affordable and pocket friendly price, these New Drug Delivery System products even have longer shelf -life.

These Dual Chamber Bags launched by Gufic are 2-Chamber IV Bags made up of polypropylene (DEHP free) with a peelable aluminium foil allowing the storage of unstable drugs which needs reconstitution just before the administration to the patient. The peelable seal separates lyophilized (or powder) drug and its diluent. Moreover, the product complies with the US and EU pharmacopoeias and it is manufactured in ISO7 clean room under cGMP.

One of the most important USPs of these ready-to-use Dual Chamber Bags by Gufic is that they prevent contamination and protects the potency and efficacy of the drug. These bags also offer ease of handling at the time of reconstitution and also help in avoiding the dilution errors since the drug is present with the exact required quantity of the diluent to be used. It can be reconstituted just before administration by simply peeling off the aluminium foil and folding & squeezing the bag, thus the diluent enters the drug chamber and mixes with the drug. It is then directly administered as IV infusion to the patient with the help of IV tubes.

Previous News
  Gufic BioSciences standalone net profit rises 158.95% in the March 2021 quarter
 ( Results - Announcements 05-Jun-21   07:42 )
  Board of Gufic BioSciences recommends final dividend
 ( Corporate News - 05-Jun-21   10:29 )
  Gufic BioSciences to conduct AGM
 ( Corporate News - 05-Sep-23   15:21 )
  Gufic BioSciences standalone net profit rises 11.33% in the September 2018 quarter
 ( Results - Announcements 15-Nov-18   13:47 )
  Gufic Bio rises on TGA, ANVISA nod for Parecoxib injection
 ( Hot Pursuit - 12-Sep-23   11:25 )
  Gufic BioSciences standalone net profit rises 279.77% in the September 2020 quarter
 ( Results - Announcements 13-Nov-20   08:31 )
  Gufic BioSciences receives ratings action from CRISIL
 ( Corporate News - 08-Apr-22   11:47 )
  Gufic BioSciences standalone net profit rises 472.38% in the March 2019 quarter
 ( Results - Announcements 03-Jun-19   08:46 )
  Board of Gufic BioSciences accepts cessation of director
 ( Corporate News - 15-Sep-20   09:05 )
  Gufic BioSciences AGM scheduled
 ( Corporate News - 10-Sep-19   14:47 )
  Gufic BioSciences standalone net profit rises 255.88% in the December 2015 quarter
 ( Results - Announcements 13-Feb-16   09:08 )
Other Stories
  JSW Steel to conduct AGM
  02-Jul-24   17:04
  Maithan Alloys schedules AGM
  02-Jul-24   17:04
  Puravankara to develop 7.26-acre land parcel in Hebbagodi, Bengaluru
  02-Jul-24   16:33
  Jyoti CNC Automation receives upgrade in credit ratings for bank facilities
  02-Jul-24   16:31
  NLC India records 22% growth in Lignite production in Q1 FY25
  02-Jul-24   16:29
  Indian Highway Concessions Trust schedules AGM
  02-Jul-24   16:01
  Yunik Managing Advisors schedules AGM
  02-Jul-24   16:01
  Ceeta Industries schedules AGM
  02-Jul-24   16:01
  CRISIL schedules board meeting
  02-Jul-24   15:32
  KM Sugar Mills AGM scheduled
  02-Jul-24   15:32
Back Top